Marc Agronin, MD
Psychiatry · Miami, FLNPI 1831205434
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $45,237 of the $65,678 with a category attached, or 68.9%. 11 manufacturers reported payments, led by Otsuka Pharmaceutical Development & Commercialization, Inc. at 43.5% of the total. Among psychiatry clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $925.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$29K
- Biogen$11K
- Otsuka America Pharmaceutical, Inc.$9K
- Axsome Therapeutics, Inc.$7K
- Corium, LLC$6K
- Eli Lilly$2K
- plus $2K from 5 others
Across 290 payments — averaging $13,582 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eisai Inc.$1.1M
- Biogen$857K
- Eli Lilly$849K
- Janssen Research & Development, LLC$496K
- Genentech, Inc.$244K
- F. Hoffmann-la Roche AG$107K
- plus $251K from 9 others
What the payments were for
- Consulting fees$45,23769%
- Speaking & faculty fees$16,53825%
- Travel & lodging$2,7264%
- Food & beverage$8801%
- Education$2970%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 34 | $28,560 |
| Biogen | 7 | $11,292 |
| Otsuka America Pharmaceutical, Inc. | 12 | $8,681 |
| Axsome Therapeutics, Inc. | 6 | $7,111 |
| Corium, LLC | 3 | $6,293 |
| Eli Lilly | 1 | $2,231 |
| F. Hoffmann-la Roche AG | 1 | $830 |
| Bioxcel Therapeutics, Inc. | 1 | $500 |
| Eisai Inc. | 4 | $152 |
| Acadia Pharmaceuticals Inc | 1 | $15 |
| Osiris Therapeutics Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$65,678 in reported general payments places this provider in the 95th percentile of 2,059 psychiatry providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NamzaricMemantine Hcl/Donepezil Hcl | 11 | $6,311 |
| Duloxetine Hcl | 38 | $3,043 |
| Memantine Hcl | 82 | $2,718 |
| Fluvoxamine Maleate ErFluvoxamine Maleate | 12 | $2,360 |
| Mirtazapine | 89 | $2,328 |
| Donepezil Hcl | 101 | $1,484 |
| Aripiprazole | 51 | $1,477 |
| Quetiapine Fumarate | 66 | $1,422 |
| Galantamine ErGalantamine Hbr | 19 | $1,358 |
| Escitalopram Oxalate | 98 | $1,137 |
| Rivastigmine | 12 | $971 |
| Divalproex Sodium | 12 | $870 |
| Bupropion XlBupropion Hcl | 28 | $861 |
| Sertraline Hcl | 47 | $767 |
| Lorazepam | 37 | $583 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Miami
- Kenny PerezMiami$453K
- Erik CabreraMiami$357K
- Miguel FloresMiami$176K
- Pedro RodriguezMiami$96K
- John NewcomerMiami$96K
- Patricia JunqueraMiami$80K
- Andrew CutlerLakewood Ranch$5.7M
- Richard JacksonBoca Raton$3.6M
- Ilan MelnickCoral Gables$2.8M
- Todd BroderSt Augustine$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.